Bridgebio Oncology Therapeutics Return on Net Operating Assets Analysis

Bridgebio Oncology Therapeutics, Inc. (BBOT)

8.73 -0.02 (-0.23%) USD | NASDAQ | May 19, 16:00

8.73 0.00 (0.00%) After-Hours: 18:15

View Return on Net Operating Assets for BBOT.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Return on Net Operating Assets Chart

Start Trial

View Historical Data

Start Trial

View Return on Net Operating Assets Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Return on Net Operating Assets Benchmarks

Start Trial

Praxis Precision Medicines, Inc.	Upgrade
Bicara Therapeutics, Inc.	Upgrade
Amgen, Inc.	Upgrade
BioMarin Pharmaceutical, Inc.	Upgrade
Gilead Sciences, Inc.	Upgrade